Sorrento Therapeutics’s (NASDAQ: SRNE) fully-owned unit SmartPharm Therapeutics has accepted a contract to provide quick protection measures against COVID-19. The contract was granted to SmartPharm by DARPA and is co-supported by JPEO-CBRND. The DRAPA/JPEO deal will offer support to speed up